您的位置: 首页 > 农业专利 > 详情页

MIR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)
专利权人:
Miragen Therapeutics; Inc.
发明人:
Rodman, David,Seto, Anita,Dalby, Christina,Jackson, Aimee,Beatty, Xuan
申请号:
AU2019232918
公开号:
AU2019232918A1
申请日:
2019.09.20
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
#$%^&*AU2019232918A120191010.pdf#####ABSTRACT The present invention provides oligonucleotide inhibitors of miR-155 and compositions thereof. The invention further provides methods for treating cancer such as a T cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of miR-155. The invention also provides methods for reducing or inhibiting the proliferation of malignant T cells by administering an oligonucleotide inhibitor of miR-155.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充